Nektar Therapeutics (NKTR) Cash & Current Investments (2010 - 2026)
Nektar Therapeutics (NKTR) reported Cash & Current Investments of $684.34 million for Q2 2026, up 289.0% from $175.9 million a year earlier and up 20.4% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Nektar Therapeutics posted Cash & Current Investments of $245.75 million, down 3.7% from FY2024.
- Cash & Current Investments has declined for seven consecutive years, with a five-year compound annual growth rate of -25.4% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $255.23 million in FY2024 (-15.9%), $303.62 million in FY2023 (-39.9%), $504.98 million in FY2022 (-31.2%) and $733.96 million in FY2021 (-30.9%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Current Investments since Q4 2021.
- Year over year, Cash & Current Investments gained in three of the last eight quarters, with growth averaging 43.3%.
- The high point for year-over-year Cash & Current Investments in five years was Q2 2026 (growth of 289.0%); the low point was Q3 2022 (a decline of 40.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $568.6 million (Q1 2026), $245.75 million (Q4 2025) and $270.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Nektar Therapeutics | 1.44 Bn | -328.37 Mn | - | 684.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 684.34 Mn |
| Mar 31, 2026 | 568.60 Mn |
| Dec 31, 2025 | 245.75 Mn |
| Sep 30, 2025 | 270.21 Mn |
| Jun 30, 2025 | 175.90 Mn |
| Mar 31, 2025 | 218.63 Mn |
| Dec 31, 2024 | 255.23 Mn |
| Sep 30, 2024 | 244.50 Mn |
| Jun 30, 2024 | 271.24 Mn |
| Mar 31, 2024 | 289.24 Mn |
| Dec 31, 2023 | 303.62 Mn |
| Sep 30, 2023 | 372.66 Mn |
| Jun 30, 2023 | 409.43 Mn |
| Mar 31, 2023 | 456.83 Mn |
| Dec 31, 2022 | 504.98 Mn |
| Sep 30, 2022 | 546.39 Mn |
| Jun 30, 2022 | 619.32 Mn |
| Mar 31, 2022 | 667.03 Mn |
| Dec 31, 2021 | 733.96 Mn |
| Sep 30, 2021 | 921.08 Mn |
API Access
Nektar Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();